Davita Inc vs Raymond James Financial, Inc. — how do they compare? Davita Inc trades at $178.5 (market cap $11.38B), while Raymond James Financial, Inc. trades at $180.02 (market cap $34.63B). The key difference: Raymond James Financial, Inc. is far larger — about 3× Davita Inc's market cap, and Raymond James Financial, Inc. pays a 1.2% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | RJF | |
|---|---|---|
Market Cap | $11.38B | $34.63B |
Sector | Health | Financials |
52-Week High | $240.96 | $180.55 |
52-Week Low | $103.87 | $140.89 |
Enterprise Value | $24.10B | — |
Dividend Yield | — | 1.2% |
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →